Key facts
- It has raised $8.5M; the latest was Seed Round ($8.5M) in Mar 2025.
- Notable investors include Blue Cross Blue Shield of Massachusetts, Independence Blue Cross, Blue Cross Blue Shield of Michigan, Highmark, Blue Shield of California.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Evio (Enterprise Systems)
- ·The full record, as it builds
Funding rounds
No funding rounds for Evio (Enterprise Systems) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Evio (Enterprise Systems)
Provider of pharmacy health plans intended to address the high cost of medications. The company focuses on data and evidence-based practices about specific drugs and their performance, enabling patients to get the right medication in a simple and affordable way.
- Sector
- Healthcare
- HQ
- Denver, CO, United States
- Founded
- 2019
- Employees
- 4
- Website
- evio.com/
- Ownership
- Privately Held (backing)
Evio (Enterprise Systems) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Evio (Enterprise Systems) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Evio (Enterprise Systems) in its N-PORT filings yet. We sweep new filings monthly.